Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO964 | Homalium laurifolium | Species | Salicaceae | Eukaryota | UNPD* | |||
NPO12488 | Bupleurum rigidum | Species | Apiaceae | Eukaryota | UNPD* | |||
NPO9166 | Monascus rubropunctatus | Species | Fellodistomidae | Eukaryota | UNPD* | |||
NPO13059 | Abies webbiana | Species | Pinaceae | Eukaryota | UNPD* | |||
NPO10274 | Pothomorphe peltata | NA | NA | NA | UNPD* | |||
NPO3968 | Dracontium loretense | Species | Araceae | Eukaryota | UNPD* | |||
NPO26094 | Stolonica socialis | Species | Styelidae | Eukaryota | UNPD* | |||
NPO12383 | Frullania brasiliensis | Species | Frullaniaceae | Eukaryota | UNPD* | |||
NPO26195 | Tephrosia crassifolia | Species | Geometridae | Eukaryota | UNPD* | |||
NPO7158 | Schefflera venulosa | Species | Araliaceae | Eukaryota | UNPD* | |||
NPO6544 | Carpesium longifolium | Species | Asteraceae | Eukaryota | UNPD* | |||
NPO23642 | Penicillium tardum | Species | Aspergillaceae | Eukaryota | UNPD* | |||
NPO4251 | Photorhabdus luminescens | Species | Morganellaceae | Bacteria | UNPD* | |||
NPO230 | Palisota barteri | Species | Commelinaceae | Eukaryota | UNPD* | |||
NPO11137 | Dichotomanthes tristaniicarpa | Species | Rosaceae | Eukaryota | UNPD* | |||
NPO6428 | Euphorbia wangii | Species | Euphorbiaceae | Eukaryota | UNPD* | |||
NPO6648 | Piper retrofractum | Species | Piperaceae | Eukaryota | UNPD* | |||
NPO2393 | Matsumurella chinensis | Species | Lamiaceae | Eukaryota | UNPD* | |||
NPO16302 | Piper guineense | Species | Piperaceae | Eukaryota | TCM_Taiwan* | |||
NPO1797 | Homo sapiens | Species | Hominidae | Eukaryota | blood serum |
PMID[25518943] |
||
NPO11511 | Cochlearia officinalis | Species | Brassicaceae | Eukaryota | UNPD* | |||
NPO26237 | Piper longum | Species | Piperaceae | Eukaryota | TCM_Taiwan* | |||
NPO28938 | Artemisia coerulescens | Species | Asteraceae | Eukaryota | UNPD* | |||
NPO26872 | Piper betle | Species | Piperaceae | Eukaryota | DOI[10.1016/S0031-9422(98)00208-8] | |||
NPO12125 | Pseudomonas stutzeri | Species | Pseudomonadaceae | Bacteria | UNPD* | |||
NPO28928 | Piper nigrum | Species | Piperaceae | Eukaryota |
PMID[10575373] |
|||
NPO28928 | Piper nigrum | Species | Piperaceae | Eukaryota |
PMID[23102654] |
|||
NPO30351 | Piper khasianum | Species | Piperaceae | Eukaryota | DOI[10.1016/S0031-9422(98)00208-8] | |||
NPO26237 | Piper longum | Species | Piperaceae | Eukaryota |
PMID[23434420] |
|||
NPO27487 | Silene banksia | Species | Caryophyllaceae | Eukaryota | UNPD* | |||
NPO876 | Didymosphaeria enalia | Species | Didymosphaeriaceae | Eukaryota | UNPD* | |||
NPO10666 | Verbesina virginica | Species | Asteraceae | Eukaryota | UNPD* | |||
NPO8639 | Agaricus xanthodermus | Species | Agaricaceae | Eukaryota | UNPD* | |||
NPO29556 | Piperis longi fructus | NA | NA | NA | TCMSP* | |||
NPO6880 | Crocus corsicus | Species | Iridaceae | Eukaryota | UNPD* | |||
NPO26237 | Piper longum | Species | Piperaceae | Eukaryota | TM-MC* | |||
NPO7536 | Mycoplasma mycoides | Species | Mycoplasmataceae | Bacteria | UNPD* | |||
NPO28928 | Piper nigrum | Species | Piperaceae | Eukaryota | TM-MC* | |||
NPO2840 | Podocarpus minor | Species | Podocarpaceae | Eukaryota | UNPD* | |||
NPO26542 | Rubia cordifolia | Species | Rubiaceae | Eukaryota | TM-MC* | |||
NPO10459 | Brickellia longifolia | Species | Asteraceae | Eukaryota | UNPD* | |||
NPO43 | Leifsonia aquatica | Species | Microbacteriaceae | Bacteria | UNPD* | |||
NPO9950 | Coelogyne nitida | Species | Orchidaceae | Eukaryota | UNPD* |
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT317 | Uncleic Acid | Nucleic Acid | Inhibition | = | 27 | % | 10.1016/0960-894X(95)00272-U | |
NPT317 | Uncleic Acid | Nucleic Acid | Inhibition | = | 47 | % | 10.1016/0960-894X(95)00272-U | |
NPT317 | Uncleic Acid | Nucleic Acid | Inhibition | = | 57 | % | 10.1016/0960-894X(95)00272-U | |
NPT580 | Organism | Trypanosoma cruzi | Trypanosoma cruzi | IC50 | = | 7360 | nM | 15177472 |
NPT580 | Organism | Trypanosoma cruzi | Trypanosoma cruzi | IC50 | = | 4910 | nM | 15177472 |
NPT32 | Organism | Mus musculus | Mus musculus | Inhibition | = | 0.3 | % | 18289853 |
NPT32 | Organism | Mus musculus | Mus musculus | Inhibition | = | 50.7 | % | 18289853 |
NPT32 | Organism | Mus musculus | Mus musculus | Inhibition | = | 96.1 | % | 18289853 |
NPT32 | Organism | Mus musculus | Mus musculus | Inhibition | = | 23.2 | % | 18289853 |
NPT32 | Organism | Mus musculus | Mus musculus | Inhibition | = | 51.1 | % | 18289853 |
NPT32 | Organism | Mus musculus | Mus musculus | Inhibition | = | 94.3 | % | 18289853 |
NPT993 | Cell Line | Hepatocyte | Mus musculus | Inhibition | = | 23 | % | 18289853 |
NPT993 | Cell Line | Hepatocyte | Mus musculus | Inhibition | = | 46 | % | 18289853 |
NPT993 | Cell Line | Hepatocyte | Mus musculus | Inhibition | = | 68 | % | 18289853 |
NPT32 | Organism | Mus musculus | Mus musculus | Inhibition | = | 15.7 | % | 18289853 |
NPT32 | Organism | Mus musculus | Mus musculus | Inhibition | = | 9.2 | % | 18289853 |
NPT32 | Organism | Mus musculus | Mus musculus | Inhibition | = | -2.2 | % | 18289853 |
NPT993 | Cell Line | Hepatocyte | Mus musculus | Activity | = | 72.4 | % | 18289853 |
NPT993 | Cell Line | Hepatocyte | Mus musculus | Activity | = | 76.1 | % | 18289853 |
NPT993 | Cell Line | Hepatocyte | Mus musculus | Activity | = | 84.3 | % | 18289853 |
NPT993 | Cell Line | Hepatocyte | Mus musculus | Activity | = | 40.6 | % | 18289853 |
NPT993 | Cell Line | Hepatocyte | Mus musculus | Activity | = | 36.5 | % | 18289853 |
NPT993 | Cell Line | Hepatocyte | Mus musculus | Activity | = | 29.2 | % | 18289853 |
NPT1460 | Cell Line | L929 | Mus musculus | Activity | = | 64 | % | 18289853 |
NPT1460 | Cell Line | L929 | Mus musculus | Activity | = | 66.2 | % | 18289853 |
NPT1460 | Cell Line | L929 | Mus musculus | Activity | = | 92.2 | % | 18289853 |
NPT580 | Organism | Trypanosoma cruzi | Trypanosoma cruzi | IC50 | = | 7310 | nM | 18226906 |
NPT580 | Organism | Trypanosoma cruzi | Trypanosoma cruzi | IC50 | = | 4910 | nM | 18226906 |
NPT520 | Cell Line | 3T3-L1 | Mus musculus | Activity | = | -1.2 | % | 18477507 |
NPT520 | Cell Line | 3T3-L1 | Mus musculus | Activity | = | -3.9 | % | 18477507 |
NPT520 | Cell Line | 3T3-L1 | Mus musculus | Activity | = | -14.2 | % | 18477507 |
NPT991 | Individual Protein | Trypanothione reductase | Trypanosoma cruzi | Inhibition | = | 11 | % | 18558492 |
NPT2 | Others | Unspecified | MIC | = | 2 | ug/ml | 18524600 | |
NPT2794 | Individual Protein | Quinolone resistance protein norA | Staphylococcus aureus | FC | = | 2 | 18848780 | |
NPT2794 | Individual Protein | Quinolone resistance protein norA | Staphylococcus aureus | MIC | > | 100 | ug/ml | 19523722 |
NPT2794 | Individual Protein | Quinolone resistance protein norA | Staphylococcus aureus | FC | = | 2 | 19523722 | |
NPT1460 | Cell Line | L929 | Mus musculus | Inhibition | = | 22 | % | 19775895 |
NPT993 | Cell Line | Hepatocyte | Mus musculus | Inhibition | = | -9 | % | 19775895 |
NPT2 | Others | Unspecified | Inhibition | = | 2 | % | 19775895 | |
NPT1460 | Cell Line | L929 | Mus musculus | Inhibition | = | 82 | % | 19775895 |
NPT993 | Cell Line | Hepatocyte | Mus musculus | Inhibition | = | 2 | % | 19775895 |
NPT1460 | Cell Line | L929 | Mus musculus | Inhibition | = | 10 | % | 19775895 |
NPT993 | Cell Line | Hepatocyte | Mus musculus | Inhibition | = | 68 | % | 19775895 |
NPT993 | Cell Line | Hepatocyte | Mus musculus | Inhibition | = | 46 | % | 19775895 |
NPT2 | Others | Unspecified | Inhibition | = | 49 | % | 19775895 | |
NPT993 | Cell Line | Hepatocyte | Mus musculus | Inhibition | = | 9 | % | 19775895 |
NPT2 | Others | Unspecified | Inhibition | = | 11 | % | 19775895 | |
NPT1460 | Cell Line | L929 | Mus musculus | Inhibition | = | 17 | % | 19775895 |
NPT993 | Cell Line | Hepatocyte | Mus musculus | Inhibition | = | 23 | % | 19775895 |
NPT993 | Cell Line | Hepatocyte | Mus musculus | Inhibition | = | 6 | % | 19775895 |
NPT32 | Organism | Mus musculus | Mus musculus | Inhibition | = | -2.2 | % | 19775895 |
NPT32 | Organism | Mus musculus | Mus musculus | Inhibition | = | 0.3 | % | 19775895 |
NPT32 | Organism | Mus musculus | Mus musculus | Inhibition | = | 9.2 | % | 19775895 |
NPT993 | Cell Line | Hepatocyte | Mus musculus | IC50 | = | 12000 | nM | 19775895 |
NPT32 | Organism | Mus musculus | Mus musculus | Inhibition | = | 15.7 | % | 19775895 |
NPT32 | Organism | Mus musculus | Mus musculus | Inhibition | = | 23.2 | % | 19775895 |
NPT1460 | Cell Line | L929 | Mus musculus | IC50 | = | 42000 | nM | 19775895 |
NPT32 | Organism | Mus musculus | Mus musculus | Inhibition | = | 50.7 | % | 19775895 |
NPT32 | Organism | Mus musculus | Mus musculus | Inhibition | = | 51.1 | % | 19775895 |
NPT32 | Organism | Mus musculus | Mus musculus | Inhibition | = | 94.3 | % | 19775895 |
NPT32 | Organism | Mus musculus | Mus musculus | Inhibition | = | 96.1 | % | 19775895 |
NPT1488 | Individual Protein | Monoamine oxidase A | Rattus norvegicus | Ki | = | 49300 | nM | 19969454 |
NPT1487 | Individual Protein | Monoamine oxidase B | Rattus norvegicus | Ki | = | 91300 | nM | 19969454 |
NPT892 | Individual Protein | Monoamine oxidase A | Mus musculus | Ki | = | 19000 | nM | 19969454 |
NPT893 | Individual Protein | Monoamine oxidase B | Mus musculus | Ki | = | 3190 | nM | 19969454 |
NPT1460 | Cell Line | L929 | Mus musculus | Inhibition | = | 5.5 | % | 20159656 |
NPT1460 | Cell Line | L929 | Mus musculus | Inhibition | = | 5.3 | % | 20159656 |
NPT1460 | Cell Line | L929 | Mus musculus | Inhibition | = | 10.6 | % | 20159656 |
NPT1460 | Cell Line | L929 | Mus musculus | Inhibition | = | 41.8 | % | 20159656 |
NPT2 | Others | Unspecified | Activity | = | 226 | % | 20085307 | |
NPT2 | Others | Unspecified | Activity | = | 302 | % | 20085307 | |
NPT2 | Others | Unspecified | EC50 | = | 52000 | nM | 20085307 | |
NPT2 | Others | Unspecified | Activity | = | 334 | % | 20085307 | |
NPT2 | Others | Unspecified | Activity | = | 204 | % | 20085307 | |
NPT2 | Others | Unspecified | Activity | = | 391 | % | 20085307 | |
NPT2 | Others | Unspecified | IC50 | = | 1200000 | nM | 20085307 | |
NPT472 | Individual Protein | Vanilloid receptor | Homo sapiens | EC50 | = | 3162.28 | nM | 20381363 |
NPT633 | Organism | Leishmania donovani | Leishmania donovani | IC50 | = | 752000 | nM | 20546981 |
NPT633 | Organism | Leishmania donovani | Leishmania donovani | IC50 | = | 2558000 | nM | 20546981 |
NPT927 | Cell Line | PBMC | Homo sapiens | Activity | = | 7 | % | 20546981 |
NPT927 | Cell Line | PBMC | Homo sapiens | Activity | = | 10 | % | 20546981 |
NPT580 | Organism | Trypanosoma cruzi | Trypanosoma cruzi | IC50 | = | 5000 | nM | 20185316 |
NPT472 | Individual Protein | Vanilloid receptor | Homo sapiens | Activity | = | 0.01 | nM | 16408004 |
NPT2794 | Individual Protein | Quinolone resistance protein norA | Staphylococcus aureus | FC | = | 2 | 20605275 | |
NPT149 | Individual Protein | Endoplasmic reticulum-associated amyloid beta-peptide-binding protein | Homo sapiens | Potency | = | 39810.7 | nM | PubChem BioAssay data set |
NPT48 | Individual Protein | Lysine-specific demethylase 4D-like | Homo sapiens | Potency | = | 31622.8 | nM | PubChem BioAssay data set |
NPT2 | Others | Unspecified | Potency | = | 31622.8 | nM | PubChem BioAssay data set | |
NPT537 | Individual Protein | Ras-related protein Rab-9A | Homo sapiens | Potency | = | 2511.9 | nM | PubChem BioAssay data set |
NPT93 | Individual Protein | Survival motor neuron protein | Homo sapiens | Potency | = | 14125.4 | nM | PubChem BioAssay data set |
NPT531 | Individual Protein | Nuclear receptor ROR-gamma | Mus musculus | Potency | = | 5623.4 | nM | PubChem BioAssay data set |
NPT94 | Individual Protein | Aldehyde dehydrogenase 1A1 | Homo sapiens | Potency | = | 39810.7 | nM | PubChem BioAssay data set |
NPT3 | Individual Protein | Thioredoxin glutathione reductase | Schistosoma mansoni | Potency | = | 39810.7 | nM | PubChem BioAssay data set |
NPT282 | Individual Protein | MAP kinase ERK2 | Homo sapiens | Potency | = | 39810.7 | nM | PubChem BioAssay data set |
NPT56 | Individual Protein | Beta-lactamase AmpC | Escherichia coli K-12 | Potency | = | 44668.4 | nM | PubChem BioAssay data set |
NPT538 | Individual Protein | Niemann-Pick C1 protein | Homo sapiens | Potency | = | 2511.9 | nM | PubChem BioAssay data set |
NPT151 | Individual Protein | 15-hydroxyprostaglandin dehydrogenase [NAD+] | Homo sapiens | Potency | = | 15848.9 | nM | PubChem BioAssay data set |
NPT109 | Individual Protein | Cytochrome P450 3A4 | Homo sapiens | Potency | = | 12589.3 | nM | PubChem BioAssay data set |
NPT152 | Individual Protein | Nuclear factor erythroid 2-related factor 2 | Homo sapiens | Potency | 20596.2 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 20596.2 | nM | PubChem BioAssay data set | ||
NPT64 | Individual Protein | ATPase family AAA domain-containing protein 5 | Homo sapiens | Potency | 11577.4 | nM | PubChem BioAssay data set | |
NPT64 | Individual Protein | ATPase family AAA domain-containing protein 5 | Homo sapiens | Potency | 10318.3 | nM | PubChem BioAssay data set | |
NPT546 | Individual Protein | Retinoid X receptor alpha | Homo sapiens | Potency | 35481.3 | nM | PubChem BioAssay data set | |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | Potency | 7375.3 | nM | PubChem BioAssay data set | |
NPT8 | Individual Protein | DNA polymerase iota | Homo sapiens | Potency | 89125.1 | nM | PubChem BioAssay data set | |
NPT540 | Individual Protein | Bile acid receptor FXR | Homo sapiens | Potency | 44668.4 | nM | PubChem BioAssay data set | |
NPT249 | Individual Protein | Glucocorticoid receptor | Homo sapiens | Potency | 44668.4 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 10000 | nM | PubChem BioAssay data set | ||
NPT99 | Individual Protein | Peroxisome proliferator-activated receptor gamma | Homo sapiens | Potency | 39810.7 | nM | PubChem BioAssay data set | |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | Potency | 4653.5 | nM | PubChem BioAssay data set | |
NPT99 | Individual Protein | Peroxisome proliferator-activated receptor gamma | Homo sapiens | Potency | 50118.7 | nM | PubChem BioAssay data set | |
NPT484 | Individual Protein | Luciferin 4-monooxygenase | Photinus pyralis | Potency | 8492.1 | nM | PubChem BioAssay data set | |
NPT1488 | Individual Protein | Monoamine oxidase A | Rattus norvegicus | IC50 | = | 404 | nM | 22475561 |
NPT1487 | Individual Protein | Monoamine oxidase B | Rattus norvegicus | IC50 | = | 260 | nM | 22475561 |
NPT2 | Others | Unspecified | Ratio IC50 | = | 1.55 | 22475561 | ||
NPT668 | Individual Protein | P-glycoprotein 1 | Homo sapiens | IC50 | = | 15500 | nM | 12130727 |
NPT668 | Individual Protein | P-glycoprotein 1 | Homo sapiens | IC50 | = | 74100 | nM | 12130727 |
NPT155 | Individual Protein | Aryl hydrocarbon receptor | Homo sapiens | Potency | 14125.4 | nM | PubChem BioAssay data set | |
NPT156 | Individual Protein | Sphingomyelin phosphodiesterase | Homo sapiens | Potency | 31622.8 | nM | PubChem BioAssay data set | |
NPT478 | Individual Protein | Ataxin-2 | Homo sapiens | Potency | 19952.6 | nM | PubChem BioAssay data set | |
NPT157 | Individual Protein | Breast cancer type 1 susceptibility protein | Homo sapiens | Potency | 8912.5 | nM | PubChem BioAssay data set | |
NPT158 | Individual Protein | Nuclear receptor subfamily 1 group I member 2 | Rattus norvegicus | Potency | 7079.5 | nM | PubChem BioAssay data set | |
NPT66 | Individual Protein | Acetylcholinesterase | Electrophorus electricus | Inhibition | = | -0.1 | % | 23062825 |
NPT67 | Individual Protein | Cholinesterase | Equus caballus | Inhibition | = | 16.77 | % | 23062825 |
NPT589 | Individual Protein | Serum albumin | Bos taurus | Activity | = | 50 | % | 23102654 |
NPT582 | Individual Protein | Monoamine oxidase B | Homo sapiens | IC50 | = | 483 | nM | 23102654 |
NPT261 | Individual Protein | Monoamine oxidase A | Homo sapiens | IC50 | = | 58980 | nM | 23102654 |
NPT90 | Cell Line | DU-145 | Homo sapiens | IC50 | > | 50000 | nM | 10.1007/s00044-010-9500-5 |
NPT306 | Cell Line | PC-3 | Homo sapiens | IC50 | > | 50000 | nM | 10.1007/s00044-010-9500-5 |
NPT1171 | Cell Line | HEp-2 | Homo sapiens | IC50 | = | 70000 | nM | 10.1007/s00044-010-9500-5 |
NPT407 | Cell Line | COLO 205 | Homo sapiens | IC50 | = | 46000 | nM | 10.1007/s00044-010-9500-5 |
NPT83 | Cell Line | MCF7 | Homo sapiens | IC50 | = | 99000 | nM | 10.1007/s00044-010-9500-5 |
NPT744 | Cell Line | IMR-32 | Homo sapiens | IC50 | = | 89000 | nM | 10.1007/s00044-010-9500-5 |
NPT2564 | Organism | Blumeria graminis | Blumeria graminis | Activity | = | 0 | % | 10.1016/S0261-2194(00)00172-1 |
NPT829 | Organism | Puccinia recondita | Puccinia recondita | Activity | = | 0 | % | 10.1016/S0261-2194(00)00172-1 |
NPT825 | Organism | Phytophthora infestans | Phytophthora infestans | Activity | = | 0 | % | 10.1016/S0261-2194(00)00172-1 |
NPT635 | Organism | Botryotinia fuckeliana | Botryotinia fuckeliana | Activity | = | 0 | % | 10.1016/S0261-2194(00)00172-1 |
NPT529 | Organism | Rhizoctonia solani | Rhizoctonia solani | Activity | = | 0 | % | 10.1016/S0261-2194(00)00172-1 |
NPT1198 | Organism | Magnaporthe grisea | Magnaporthe grisea | Activity | = | 0 | % | 10.1016/S0261-2194(00)00172-1 |
NPT580 | Organism | Trypanosoma cruzi | Trypanosoma cruzi | IC50 | = | 233000 | nM | 10.1007/s00044-008-9161-9 |
NPT1381 | Organism | Aedes aegypti | Aedes aegypti | LD50 | = | 8.13 | ug | 22069667 |
NPT18 | Organism | Pseudomonas aeruginosa | Pseudomonas aeruginosa | MIC | = | 100 | ug/ml | 10.1007/s00044-013-0541-4 |
NPT16 | Organism | Staphylococcus aureus | Staphylococcus aureus | MIC | = | 300 | ug/ml | 10.1007/s00044-013-0541-4 |
NPT79 | Organism | Bacillus subtilis | Bacillus subtilis | MIC | = | 500 | ug/ml | 10.1007/s00044-013-0541-4 |
NPT3152 | Organism | Shigella dysenteriae | Shigella dysenteriae | MIC | = | 600 | ug/ml | 10.1007/s00044-013-0541-4 |
NPT1242 | Organism | Salmonella typhi | Salmonella enterica subsp. enterica serovar Typhi | MIC | = | 200 | ug/ml | 10.1007/s00044-013-0541-4 |
NPT173 | Organism | Klebsiella pneumoniae | Klebsiella pneumoniae | MIC | = | 200 | ug/ml | 10.1007/s00044-013-0541-4 |
NPT19 | Organism | Escherichia coli | Escherichia coli | MIC | = | 300 | ug/ml | 10.1007/s00044-013-0541-4 |
NPT83 | Cell Line | MCF7 | Homo sapiens | IC50 | = | 990 | nM | 10.1007/s00044-013-0541-4 |
NPT165 | Cell Line | HeLa | Homo sapiens | IC50 | = | 950 | nM | 10.1007/s00044-013-0541-4 |
NPT1547 | Individual Protein | Cathepsin D | Homo sapiens | IC50 | = | 42300 | nM | 10.1007/s00044-012-0397-z |
NPT82 | Cell Line | MDA-MB-231 | Homo sapiens | IC50 | = | 58.45 | ug/ml | 10.1007/s00044-012-0397-z |
NPT2 | Others | Unspecified | Ratio CC50/IC50 | = | 16.8 | 23434420 | ||
NPT963 | Organism | Hepatitis B virus | Hepatitis B virus | IC50 | = | 140000 | nM | 23434420 |
NPT2 | Others | Unspecified | Ratio CC50/IC50 | = | 15.7 | 23434420 | ||
NPT963 | Organism | Hepatitis B virus | Hepatitis B virus | IC50 | = | 150000 | nM | 23434420 |
NPT2 | Others | Unspecified | CC50 | = | 2350000 | nM | 23434420 | |
NPT2 | Others | Unspecified | Potency | 29092.9 | nM | PubChem BioAssay data set | ||
NPT73 | Individual Protein | Solute carrier organic anion transporter family member 1B1 | Homo sapiens | Inhibition | = | 186.17 | % | 23571415 |
NPT72 | Individual Protein | Solute carrier organic anion transporter family member 1B3 | Homo sapiens | Inhibition | = | 97.82 | % | 23571415 |
NPT153 | Individual Protein | Androgen Receptor | Homo sapiens | Potency | 55068.7 | nM | PubChem BioAssay data set | |
NPT153 | Individual Protein | Androgen Receptor | Homo sapiens | Potency | 8634.9 | nM | PubChem BioAssay data set | |
NPT153 | Individual Protein | Androgen Receptor | Homo sapiens | Potency | 2736.2 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 3857.1 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 1371.3 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 55068.7 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 68729.1 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 1737.6 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 28183.8 | nM | PubChem BioAssay data set | ||
NPT152 | Individual Protein | Nuclear factor erythroid 2-related factor 2 | Homo sapiens | Potency | 77115.4 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 38649.2 | nM | PubChem BioAssay data set | ||
NPT152 | Individual Protein | Nuclear factor erythroid 2-related factor 2 | Homo sapiens | Potency | 15355.3 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 43742.7 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 1368.5 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 61652.4 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 54482.7 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 612.5 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 865.2 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 2169 | nM | PubChem BioAssay data set | ||
NPT152 | Individual Protein | Nuclear factor erythroid 2-related factor 2 | Homo sapiens | Potency | 2433.7 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 38900 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 61254.9 | nM | PubChem BioAssay data set | ||
NPT153 | Individual Protein | Androgen Receptor | Homo sapiens | Potency | 9708.3 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 61130.6 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 13685.4 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 3162.3 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 771.2 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 54947.7 | nM | PubChem BioAssay data set | ||
NPT106 | Individual Protein | Peroxisome proliferator-activated receptor delta | Homo sapiens | Potency | 6932.7 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 1933.1 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 10892.8 | nM | PubChem BioAssay data set | ||
NPT737 | Cell Line | HUVEC | Homo sapiens | IC50 | = | 100000 | nM | 10.1039/C2MD20216F |
NPT737 | Cell Line | HUVEC | Homo sapiens | Activity | = | 98 | % | 10.1039/C2MD20216F |
NPT1007 | Protein Complex | GABA-A receptor; alpha-1/beta-2/gamma-2 | Homo sapiens | EC50 | = | 52400 | nM | 24905252 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 0.676 | ml | 25596479 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 0.67 | ml | 25596479 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Inhibition | = | 53.69 | % | 25596479 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Inhibition | = | 54.72 | % | 25596479 |
NPT113 | Cell Line | RAW264.7 | Mus musculus | Inhibition | = | 49.67 | % | 25596479 |
NPT2 | Others | Unspecified | Potency | 6932.7 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 9771.2 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 5623.4 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 3864.9 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 3063.8 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 8652.5 | nM | PubChem BioAssay data set | ||
NPT2794 | Individual Protein | Quinolone resistance protein norA | Staphylococcus aureus | MIC | = | 4 | ug/ml | 10.1039/C4MD00196F |
NPT2794 | Individual Protein | Quinolone resistance protein norA | Staphylococcus aureus | FC | = | 2 | 10.1039/C4MD00196F | |
NPT2 | Others | Unspecified | MIC | = | 32 | ug/ml | 10.1039/C4MD00196F | |
NPT2 | Others | Unspecified | FC | = | 0 | 10.1039/C4MD00196F | ||
NPT2 | Others | Unspecified | MIC | = | 64 | ug/ml | 10.1039/C4MD00196F | |
NPT2795 | Individual Protein | Fluoroquinolone resistance protein | Staphylococcus aureus | MIC | = | 256 | ug/ml | 10.1039/C4MD00196F |
NPT2795 | Individual Protein | Fluoroquinolone resistance protein | Staphylococcus aureus | FC | = | 0 | 10.1039/C4MD00196F | |
NPT634 | Organism | Leishmania amazonensis | Leishmania amazonensis | IC50 | = | 14500 | nM | 26094119 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC136330 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
1.0 | High Similarity | NPC230698 |
1.0 | High Similarity | NPC73883 |
1.0 | High Similarity | NPC196609 |
1.0 | High Similarity | NPC277042 |
1.0 | High Similarity | NPC255817 |
1.0 | High Similarity | NPC205178 |
1.0 | High Similarity | NPC251454 |
0.9922 | High Similarity | NPC99078 |
0.9921 | High Similarity | NPC167096 |
0.9845 | High Similarity | NPC252107 |
0.9845 | High Similarity | NPC220923 |
0.9845 | High Similarity | NPC470707 |
0.9462 | High Similarity | NPC103947 |
0.9462 | High Similarity | NPC94280 |
0.9462 | High Similarity | NPC45783 |
0.9462 | High Similarity | NPC159150 |
0.9462 | High Similarity | NPC193673 |
0.9462 | High Similarity | NPC328419 |
0.9389 | High Similarity | NPC96406 |
0.9389 | High Similarity | NPC180647 |
0.9318 | High Similarity | NPC145446 |
0.9318 | High Similarity | NPC137172 |
0.9308 | High Similarity | NPC217574 |
0.9248 | High Similarity | NPC225745 |
0.9248 | High Similarity | NPC248505 |
0.9248 | High Similarity | NPC95366 |
0.9173 | High Similarity | NPC469808 |
0.9015 | High Similarity | NPC318862 |
0.8881 | High Similarity | NPC471073 |
0.8881 | High Similarity | NPC270811 |
0.8824 | High Similarity | NPC194359 |
0.8824 | High Similarity | NPC28641 |
0.8759 | High Similarity | NPC231572 |
0.8714 | High Similarity | NPC244338 |
0.8521 | High Similarity | NPC469978 |
0.8503 | High Similarity | NPC169742 |
0.8345 | Intermediate Similarity | NPC416184 |
0.8311 | Intermediate Similarity | NPC470708 |
0.8288 | Intermediate Similarity | NPC470088 |
0.8286 | Intermediate Similarity | NPC113236 |
0.8286 | Intermediate Similarity | NPC214036 |
0.8235 | Intermediate Similarity | NPC231198 |
0.8214 | Intermediate Similarity | NPC7018 |
0.8168 | Intermediate Similarity | NPC69670 |
0.8108 | Intermediate Similarity | NPC223125 |
0.8077 | Intermediate Similarity | NPC111225 |
0.806 | Intermediate Similarity | NPC256167 |
0.8043 | Intermediate Similarity | NPC470706 |
0.8015 | Intermediate Similarity | NPC199209 |
0.8015 | Intermediate Similarity | NPC212643 |
0.8 | Intermediate Similarity | NPC223124 |
0.7985 | Intermediate Similarity | NPC114845 |
0.7974 | Intermediate Similarity | NPC106786 |
0.7973 | Intermediate Similarity | NPC475959 |
0.7956 | Intermediate Similarity | NPC251466 |
0.7956 | Intermediate Similarity | NPC218323 |
0.7935 | Intermediate Similarity | NPC59567 |
0.7929 | Intermediate Similarity | NPC118419 |
0.7899 | Intermediate Similarity | NPC172403 |
0.7895 | Intermediate Similarity | NPC57501 |
0.7883 | Intermediate Similarity | NPC170583 |
0.7883 | Intermediate Similarity | NPC71105 |
0.7883 | Intermediate Similarity | NPC152186 |
0.7883 | Intermediate Similarity | NPC182147 |
0.7883 | Intermediate Similarity | NPC207541 |
0.7883 | Intermediate Similarity | NPC246133 |
0.7848 | Intermediate Similarity | NPC241055 |
0.7842 | Intermediate Similarity | NPC469977 |
0.7826 | Intermediate Similarity | NPC156944 |
0.7817 | Intermediate Similarity | NPC473463 |
0.7812 | Intermediate Similarity | NPC127326 |
0.781 | Intermediate Similarity | NPC300955 |
0.7786 | Intermediate Similarity | NPC160193 |
0.777 | Intermediate Similarity | NPC157740 |
0.777 | Intermediate Similarity | NPC191302 |
0.777 | Intermediate Similarity | NPC64948 |
0.777 | Intermediate Similarity | NPC41331 |
0.777 | Intermediate Similarity | NPC291449 |
0.777 | Intermediate Similarity | NPC99798 |
0.7763 | Intermediate Similarity | NPC148898 |
0.7762 | Intermediate Similarity | NPC11147 |
0.7752 | Intermediate Similarity | NPC31279 |
0.7721 | Intermediate Similarity | NPC193484 |
0.7714 | Intermediate Similarity | NPC147247 |
0.7714 | Intermediate Similarity | NPC246974 |
0.7697 | Intermediate Similarity | NPC119669 |
0.7692 | Intermediate Similarity | NPC284855 |
0.7692 | Intermediate Similarity | NPC282477 |
0.7662 | Intermediate Similarity | NPC41178 |
0.7662 | Intermediate Similarity | NPC76079 |
0.7662 | Intermediate Similarity | NPC138487 |
0.7662 | Intermediate Similarity | NPC78733 |
0.7662 | Intermediate Similarity | NPC93593 |
0.7662 | Intermediate Similarity | NPC216459 |
0.7658 | Intermediate Similarity | NPC306669 |
0.7658 | Intermediate Similarity | NPC168409 |
0.7655 | Intermediate Similarity | NPC193528 |
0.7651 | Intermediate Similarity | NPC145304 |
0.7647 | Intermediate Similarity | NPC233029 |
0.7647 | Intermediate Similarity | NPC210148 |
0.7626 | Intermediate Similarity | NPC85830 |
0.7622 | Intermediate Similarity | NPC266425 |
0.7616 | Intermediate Similarity | NPC37144 |
0.7616 | Intermediate Similarity | NPC59907 |
0.7613 | Intermediate Similarity | NPC31311 |
0.7613 | Intermediate Similarity | NPC234392 |
0.7613 | Intermediate Similarity | NPC146288 |
0.7605 | Intermediate Similarity | NPC471650 |
0.759 | Intermediate Similarity | NPC116007 |
0.7582 | Intermediate Similarity | NPC476579 |
0.7582 | Intermediate Similarity | NPC474852 |
0.7574 | Intermediate Similarity | NPC344161 |
0.7556 | Intermediate Similarity | NPC277460 |
0.7551 | Intermediate Similarity | NPC314682 |
0.7537 | Intermediate Similarity | NPC268317 |
0.7536 | Intermediate Similarity | NPC298486 |
0.7534 | Intermediate Similarity | NPC254610 |
0.7517 | Intermediate Similarity | NPC475828 |
0.7516 | Intermediate Similarity | NPC329640 |
0.75 | Intermediate Similarity | NPC213206 |
0.75 | Intermediate Similarity | NPC477259 |
0.75 | Intermediate Similarity | NPC169387 |
0.75 | Intermediate Similarity | NPC328750 |
0.75 | Intermediate Similarity | NPC474915 |
0.75 | Intermediate Similarity | NPC188163 |
0.7485 | Intermediate Similarity | NPC83511 |
0.7485 | Intermediate Similarity | NPC4669 |
0.7483 | Intermediate Similarity | NPC477694 |
0.7483 | Intermediate Similarity | NPC477705 |
0.7481 | Intermediate Similarity | NPC280001 |
0.7481 | Intermediate Similarity | NPC185738 |
0.7481 | Intermediate Similarity | NPC179309 |
0.7468 | Intermediate Similarity | NPC215829 |
0.7468 | Intermediate Similarity | NPC306902 |
0.7468 | Intermediate Similarity | NPC85747 |
0.7468 | Intermediate Similarity | NPC97072 |
0.7468 | Intermediate Similarity | NPC8337 |
0.7468 | Intermediate Similarity | NPC160298 |
0.7468 | Intermediate Similarity | NPC266753 |
0.7468 | Intermediate Similarity | NPC477559 |
0.7468 | Intermediate Similarity | NPC232924 |
0.7464 | Intermediate Similarity | NPC80241 |
0.7464 | Intermediate Similarity | NPC301641 |
0.7451 | Intermediate Similarity | NPC211296 |
0.7434 | Intermediate Similarity | NPC95075 |
0.7434 | Intermediate Similarity | NPC253883 |
0.7434 | Intermediate Similarity | NPC90844 |
0.7431 | Intermediate Similarity | NPC477706 |
0.7425 | Intermediate Similarity | NPC102760 |
0.7423 | Intermediate Similarity | NPC303581 |
0.7423 | Intermediate Similarity | NPC67978 |
0.7419 | Intermediate Similarity | NPC476580 |
0.7417 | Intermediate Similarity | NPC130926 |
0.7407 | Intermediate Similarity | NPC86469 |
0.7405 | Intermediate Similarity | NPC118804 |
0.7405 | Intermediate Similarity | NPC477080 |
0.7405 | Intermediate Similarity | NPC111485 |
0.7394 | Intermediate Similarity | NPC286683 |
0.7391 | Intermediate Similarity | NPC471877 |
0.7388 | Intermediate Similarity | NPC294941 |
0.7379 | Intermediate Similarity | NPC160692 |
0.7376 | Intermediate Similarity | NPC120066 |
0.7358 | Intermediate Similarity | NPC135006 |
0.7358 | Intermediate Similarity | NPC26353 |
0.7357 | Intermediate Similarity | NPC249788 |
0.7353 | Intermediate Similarity | NPC120075 |
0.7353 | Intermediate Similarity | NPC33271 |
0.7347 | Intermediate Similarity | NPC42793 |
0.7347 | Intermediate Similarity | NPC301050 |
0.7347 | Intermediate Similarity | NPC307682 |
0.7347 | Intermediate Similarity | NPC231884 |
0.7347 | Intermediate Similarity | NPC167944 |
0.7347 | Intermediate Similarity | NPC131204 |
0.7346 | Intermediate Similarity | NPC474324 |
0.7346 | Intermediate Similarity | NPC57812 |
0.7338 | Intermediate Similarity | NPC469540 |
0.7338 | Intermediate Similarity | NPC219162 |
0.7338 | Intermediate Similarity | NPC469539 |
0.7333 | Intermediate Similarity | NPC181905 |
0.7333 | Intermediate Similarity | NPC308267 |
0.7333 | Intermediate Similarity | NPC138438 |
0.7333 | Intermediate Similarity | NPC908 |
0.7329 | Intermediate Similarity | NPC232514 |
0.7329 | Intermediate Similarity | NPC276944 |
0.7329 | Intermediate Similarity | NPC238530 |
0.7329 | Intermediate Similarity | NPC35345 |
0.7329 | Intermediate Similarity | NPC225774 |
0.7324 | Intermediate Similarity | NPC301713 |
0.7315 | Intermediate Similarity | NPC226005 |
0.7305 | Intermediate Similarity | NPC27887 |
0.7303 | Intermediate Similarity | NPC185838 |
0.7301 | Intermediate Similarity | NPC475845 |
0.7297 | Intermediate Similarity | NPC253429 |
0.7297 | Intermediate Similarity | NPC230968 |
0.7297 | Intermediate Similarity | NPC102260 |
0.7292 | Intermediate Similarity | NPC200555 |
0.7292 | Intermediate Similarity | NPC476748 |
0.7292 | Intermediate Similarity | NPC196026 |
0.7285 | Intermediate Similarity | NPC136860 |
0.7285 | Intermediate Similarity | NPC128019 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC136330 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
1.0 | High Similarity | NPD2492 | Phase 1 |
0.8462 | Intermediate Similarity | NPD5297 | Approved |
0.8014 | Intermediate Similarity | NPD6783 | Clinical (unspecified phase) |
0.7881 | Intermediate Similarity | NPD1337 | Clinical (unspecified phase) |
0.7857 | Intermediate Similarity | NPD5718 | Phase 2 |
0.7823 | Intermediate Similarity | NPD5084 | Clinical (unspecified phase) |
0.7801 | Intermediate Similarity | NPD554 | Clinical (unspecified phase) |
0.7714 | Intermediate Similarity | NPD5752 | Clinical (unspecified phase) |
0.7654 | Intermediate Similarity | NPD3885 | Approved |
0.7582 | Intermediate Similarity | NPD824 | Approved |
0.7535 | Intermediate Similarity | NPD2669 | Clinical (unspecified phase) |
0.7534 | Intermediate Similarity | NPD6029 | Clinical (unspecified phase) |
0.7534 | Intermediate Similarity | NPD6028 | Clinical (unspecified phase) |
0.75 | Intermediate Similarity | NPD4664 | Clinical (unspecified phase) |
0.7484 | Intermediate Similarity | NPD7109 | Clinical (unspecified phase) |
0.7484 | Intermediate Similarity | NPD7110 | Phase 1 |
0.7481 | Intermediate Similarity | NPD5536 | Phase 2 |
0.7468 | Intermediate Similarity | NPD5604 | Discontinued |
0.7452 | Intermediate Similarity | NPD5977 | Approved |
0.7452 | Intermediate Similarity | NPD5978 | Approved |
0.7451 | Intermediate Similarity | NPD6662 | Clinical (unspecified phase) |
0.7445 | Intermediate Similarity | NPD2423 | Clinical (unspecified phase) |
0.7403 | Intermediate Similarity | NPD4210 | Discontinued |
0.7372 | Intermediate Similarity | NPD1357 | Approved |
0.7347 | Intermediate Similarity | NPD6895 | Approved |
0.7347 | Intermediate Similarity | NPD6896 | Approved |
0.7347 | Intermediate Similarity | NPD743 | Approved |
0.7333 | Intermediate Similarity | NPD4237 | Approved |
0.7333 | Intermediate Similarity | NPD4236 | Phase 3 |
0.7325 | Intermediate Similarity | NPD7945 | Clinical (unspecified phase) |
0.7284 | Intermediate Similarity | NPD4166 | Phase 2 |
0.7279 | Intermediate Similarity | NPD2653 | Approved |
0.7262 | Intermediate Similarity | NPD7280 | Phase 3 |
0.7262 | Intermediate Similarity | NPD7281 | Phase 3 |
0.7261 | Intermediate Similarity | NPD6873 | Phase 2 |
0.7261 | Intermediate Similarity | NPD6385 | Approved |
0.7261 | Intermediate Similarity | NPD6386 | Approved |
0.726 | Intermediate Similarity | NPD3142 | Approved |
0.726 | Intermediate Similarity | NPD3140 | Approved |
0.7234 | Intermediate Similarity | NPD1420 | Approved |
0.7234 | Intermediate Similarity | NPD1421 | Approved |
0.7226 | Intermediate Similarity | NPD3640 | Phase 3 |
0.7226 | Intermediate Similarity | NPD3641 | Approved |
0.7226 | Intermediate Similarity | NPD3639 | Approved |
0.7214 | Intermediate Similarity | NPD3705 | Approved |
0.7208 | Intermediate Similarity | NPD3146 | Approved |
0.7208 | Intermediate Similarity | NPD3688 | Clinical (unspecified phase) |
0.7208 | Intermediate Similarity | NPD4584 | Approved |
0.72 | Intermediate Similarity | NPD3656 | Approved |
0.7197 | Intermediate Similarity | NPD6875 | Approved |
0.7197 | Intermediate Similarity | NPD6876 | Approved |
0.7175 | Intermediate Similarity | NPD5457 | Discontinued |
0.717 | Intermediate Similarity | NPD2978 | Approved |
0.717 | Intermediate Similarity | NPD2977 | Approved |
0.7143 | Intermediate Similarity | NPD4357 | Discontinued |
0.7124 | Intermediate Similarity | NPD2219 | Phase 1 |
0.7123 | Intermediate Similarity | NPD3144 | Approved |
0.7123 | Intermediate Similarity | NPD3145 | Approved |
0.7122 | Intermediate Similarity | NPD6382 | Discontinued |
0.7114 | Intermediate Similarity | NPD6111 | Discontinued |
0.7113 | Intermediate Similarity | NPD4379 | Clinical (unspecified phase) |
0.7105 | Intermediate Similarity | NPD5177 | Phase 3 |
0.7097 | Intermediate Similarity | NPD1424 | Approved |
0.7091 | Intermediate Similarity | NPD2898 | Approved |
0.7075 | Intermediate Similarity | NPD3531 | Approved |
0.7075 | Intermediate Similarity | NPD3532 | Approved |
0.7075 | Intermediate Similarity | NPD3530 | Approved |
0.7075 | Intermediate Similarity | NPD2674 | Phase 3 |
0.7075 | Intermediate Similarity | NPD2245 | Discovery |
0.7071 | Intermediate Similarity | NPD2668 | Approved |
0.7071 | Intermediate Similarity | NPD2667 | Approved |
0.7063 | Intermediate Similarity | NPD7258 | Clinical (unspecified phase) |
0.7059 | Intermediate Similarity | NPD5481 | Discontinued |
0.7059 | Intermediate Similarity | NPD5283 | Phase 1 |
0.7047 | Intermediate Similarity | NPD4579 | Clinical (unspecified phase) |
0.7025 | Intermediate Similarity | NPD4017 | Approved |
0.7021 | Intermediate Similarity | NPD3447 | Discontinued |
0.702 | Intermediate Similarity | NPD1725 | Approved |
0.7019 | Intermediate Similarity | NPD5353 | Approved |
0.7018 | Intermediate Similarity | NPD6618 | Phase 2 |
0.7013 | Intermediate Similarity | NPD5241 | Discontinued |
0.7006 | Intermediate Similarity | NPD6030 | Approved |
0.7006 | Intermediate Similarity | NPD1670 | Discontinued |
0.7006 | Intermediate Similarity | NPD6031 | Approved |
0.7006 | Intermediate Similarity | NPD2122 | Discontinued |
0.6994 | Remote Similarity | NPD3349 | Phase 2 |
0.6993 | Remote Similarity | NPD4162 | Approved |
0.6993 | Remote Similarity | NPD3060 | Approved |
0.6992 | Remote Similarity | NPD1358 | Approved |
0.6989 | Remote Similarity | NPD6493 | Phase 3 |
0.6982 | Remote Similarity | NPD6297 | Approved |
0.6978 | Remote Similarity | NPD7607 | Clinical (unspecified phase) |
0.6974 | Remote Similarity | NPD1375 | Discontinued |
0.6968 | Remote Similarity | NPD5295 | Discontinued |
0.6968 | Remote Similarity | NPD7124 | Phase 2 |
0.6964 | Remote Similarity | NPD5312 | Approved |
0.6964 | Remote Similarity | NPD5313 | Approved |
0.6962 | Remote Similarity | NPD4124 | Clinical (unspecified phase) |
0.6951 | Remote Similarity | NPD5677 | Discontinued |
0.6944 | Remote Similarity | NPD2922 | Phase 1 |
0.6928 | Remote Similarity | NPD1372 | Clinical (unspecified phase) |
0.6928 | Remote Similarity | NPD1044 | Clinical (unspecified phase) |
0.6923 | Remote Similarity | NPD2233 | Approved |
0.6923 | Remote Similarity | NPD2232 | Approved |
0.6923 | Remote Similarity | NPD2230 | Approved |
0.6918 | Remote Similarity | NPD2040 | Clinical (unspecified phase) |
0.6917 | Remote Similarity | NPD3134 | Approved |
0.6913 | Remote Similarity | NPD3110 | Approved |
0.6913 | Remote Similarity | NPD3109 | Approved |
0.6903 | Remote Similarity | NPD5307 | Clinical (unspecified phase) |
0.6899 | Remote Similarity | NPD4727 | Phase 1 |
0.6897 | Remote Similarity | NPD7291 | Discontinued |
0.6894 | Remote Similarity | NPD3384 | Approved |
0.6894 | Remote Similarity | NPD3383 | Approved |
0.6894 | Remote Similarity | NPD3382 | Approved |
0.6892 | Remote Similarity | NPD3374 | Clinical (unspecified phase) |
0.6887 | Remote Similarity | NPD7119 | Phase 2 |
0.6886 | Remote Similarity | NPD4481 | Phase 3 |
0.6879 | Remote Similarity | NPD2595 | Approved |
0.6879 | Remote Similarity | NPD4739 | Approved |
0.6879 | Remote Similarity | NPD2594 | Approved |
0.6859 | Remote Similarity | NPD160 | Clinical (unspecified phase) |
0.6859 | Remote Similarity | NPD2120 | Phase 2 |
0.6854 | Remote Similarity | NPD5582 | Discontinued |
0.6852 | Remote Similarity | NPD6818 | Clinical (unspecified phase) |
0.6852 | Remote Similarity | NPD5772 | Approved |
0.6852 | Remote Similarity | NPD5773 | Approved |
0.6852 | Remote Similarity | NPD5563 | Clinical (unspecified phase) |
0.6849 | Remote Similarity | NPD7905 | Discontinued |
0.6835 | Remote Similarity | NPD3647 | Clinical (unspecified phase) |
0.6832 | Remote Similarity | NPD4773 | Phase 2 |
0.6832 | Remote Similarity | NPD4772 | Phase 2 |
0.6824 | Remote Similarity | NPD5746 | Approved |
0.6821 | Remote Similarity | NPD6853 | Approved |
0.6821 | Remote Similarity | NPD6851 | Approved |
0.6818 | Remote Similarity | NPD5525 | Clinical (unspecified phase) |
0.6815 | Remote Similarity | NPD6143 | Clinical (unspecified phase) |
0.6813 | Remote Similarity | NPD7261 | Clinical (unspecified phase) |
0.681 | Remote Similarity | NPD2560 | Approved |
0.681 | Remote Similarity | NPD2563 | Approved |
0.6807 | Remote Similarity | NPD6107 | Approved |
0.6802 | Remote Similarity | NPD7132 | Clinical (unspecified phase) |
0.6797 | Remote Similarity | NPD2161 | Phase 2 |
0.6792 | Remote Similarity | NPD6980 | Clinical (unspecified phase) |
0.6792 | Remote Similarity | NPD5976 | Discontinued |
0.679 | Remote Similarity | NPD7298 | Approved |
0.6788 | Remote Similarity | NPD228 | Approved |
0.6786 | Remote Similarity | NPD3596 | Phase 2 |
0.6781 | Remote Similarity | NPD4098 | Discontinued |
0.6779 | Remote Similarity | NPD1336 | Approved |
0.6778 | Remote Similarity | NPD4420 | Approved |
0.6772 | Remote Similarity | NPD2335 | Discontinued |
0.6772 | Remote Similarity | NPD1754 | Clinical (unspecified phase) |
0.6772 | Remote Similarity | NPD4123 | Phase 3 |
0.677 | Remote Similarity | NPD2592 | Discontinued |
0.6768 | Remote Similarity | NPD6788 | Approved |
0.6768 | Remote Similarity | NPD5019 | Clinical (unspecified phase) |
0.6766 | Remote Similarity | NPD6071 | Discontinued |
0.675 | Remote Similarity | NPD3687 | Approved |
0.675 | Remote Similarity | NPD3686 | Approved |
0.6748 | Remote Similarity | NPD4585 | Approved |
0.6747 | Remote Similarity | NPD2042 | Clinical (unspecified phase) |
0.6747 | Remote Similarity | NPD2041 | Clinical (unspecified phase) |
0.6735 | Remote Similarity | NPD7018 | Phase 2 |
0.6733 | Remote Similarity | NPD5745 | Approved |
0.6732 | Remote Similarity | NPD3693 | Clinical (unspecified phase) |
0.6732 | Remote Similarity | NPD4108 | Discontinued |
0.6731 | Remote Similarity | NPD5754 | Discontinued |
0.6731 | Remote Similarity | NPD6331 | Phase 2 |
0.673 | Remote Similarity | NPD1975 | Clinical (unspecified phase) |
0.6727 | Remote Similarity | NPD1309 | Phase 2 |
0.6727 | Remote Similarity | NPD1307 | Phase 2 |
0.6726 | Remote Similarity | NPD5242 | Approved |
0.6726 | Remote Similarity | NPD2388 | Discontinued |
0.6711 | Remote Similarity | NPD5163 | Phase 2 |
0.671 | Remote Similarity | NPD7153 | Discontinued |
0.6708 | Remote Similarity | NPD3866 | Clinical (unspecified phase) |
0.6707 | Remote Similarity | NPD5967 | Approved |
0.6706 | Remote Similarity | NPD2822 | Clinical (unspecified phase) |
0.6705 | Remote Similarity | NPD7549 | Discontinued |
0.669 | Remote Similarity | NPD2486 | Discontinued |
0.6688 | Remote Similarity | NPD3156 | Discontinued |
0.6667 | Remote Similarity | NPD3051 | Approved |
0.6667 | Remote Similarity | NPD7235 | Clinical (unspecified phase) |
0.6667 | Remote Similarity | NPD1039 | Discontinued |
0.6667 | Remote Similarity | NPD6377 | Clinical (unspecified phase) |
0.6667 | Remote Similarity | NPD6812 | Clinical (unspecified phase) |
0.6667 | Remote Similarity | NPD3294 | Phase 2 |
0.6648 | Remote Similarity | NPD4084 | Clinical (unspecified phase) |
0.6647 | Remote Similarity | NPD2904 | Discontinued |
0.6647 | Remote Similarity | NPD5966 | Clinical (unspecified phase) |
0.6647 | Remote Similarity | NPD7201 | Clinical (unspecified phase) |
0.6646 | Remote Similarity | NPD3281 | Clinical (unspecified phase) |
0.6645 | Remote Similarity | NPD5865 | Clinical (unspecified phase) |
0.6644 | Remote Similarity | NPD1669 | Approved |
0.663 | Remote Similarity | NPD5006 | Approved |
0.663 | Remote Similarity | NPD5564 | Approved |
0.663 | Remote Similarity | NPD5005 | Approved |
0.6629 | Remote Similarity | NPD7090 | Clinical (unspecified phase) |
0.6627 | Remote Similarity | NPD7832 | Clinical (unspecified phase) |
PubChem CID   | 638024 |
ChEMBL   | CHEMBL43185 |
ZINC   |
Molecular Weight:   | 285.14 |
ALogP:   | -0.9494 |
MLogP:   | 2.89 |
XLogP:   | 3.167 |
# Rotatable Bonds:   | 4 |
Polar Surface Area:   | 38.77 |
# H-Bond Aceptor:   | 2 |
# H-Bond Donor:   | 0 |
# Rings:   | 3 |
# Heavy Atoms:   | 21 |